F2R and myocardial ischemia: Previous studies reported that dabigatran was associated with a higher rate of myocardial ischemia due to enhanced platelet reactivity mediated by increasing platelet thrombin receptor expression (Achilles et al., 2017; Sokol et al., 2018), but whether other DOAC agents behave in the same way is unclear.